Indefinite Delivery Contract N0018924DZ013

Award Date 2/15/24
Last Date to Order 6/14/30
Funding Federal Agency
Bureau of Medicine and Surgery
Contracting Federal Agency
Naval Supply Systems Command
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
The Department of Defense awarded a series of single-award indefinite delivery contracts and delivery orders to Alere San Diego, Inc. (doing business as Immunalysis), a manufacturer of immunoassay reagents and test kits for drugs of abuse screening and other small molecule detection. The contracts, valued at over $15 million in potential orders, support substance testing programs across various federal agencies including the Departments of Defense, Transportation, Justice, and Veterans...
The Department of the Navy Bureau of Medicine and Surgery awarded a single award Indefinite Delivery Contract to Alere San Diego, Inc. DBA Immunalysis Corp. for the delivery of fentanyl and norfentanyl immunoassay reagent kits. The contract has a potential value of $2.67M and a period of performance through October 2023. Under the contract, Immunalysis Corp. was issued several firm fixed price delivery orders by Navy and Defense Health Agency customers totaling over $1.3M to supply...
The Department of the Navy Bureau of Medicine and Surgery awarded a single award indefinite delivery contract to Alere San Diego, Inc. DBA Immunalysis Corp. with a potential value of $2,355,383.84 to procure FENTANYL/NORFENTANYL IMMUNOASSAY REAGENT. No set aside provision was used for this contract. The contract includes four firm fixed price delivery orders awarded to Alere San Diego, Inc. DBA Immunalysis Corp. for quantities of FENTANYL/NORFENTANYL IMMUNOASSAY REAGENT ranging from $84,833.74...
The Indefinite Delivery Contract (IDC) award N0018925DZ009 was made by the Bureau of Medicine and Surgery, a component of the U.S. Department of the Navy, to Alere San Diego, Inc. (a subsidiary of Abbott Laboratories) to provide 6-AM reagent kits for use with Beckman Coulter AU5800 series clinical chemistry analyzers. The $750,102.21 single-award IDC has a period of performance through January 2030 and aims to support the Department of Defense's Drug Demand Reduction Program with up to 500,000...
The Naval Medical Logistics Command awarded a single-award IDV contract to Alere San Diego, Inc. DBA Immunalysis Corp. to provide fentanyl drug testing reagents for the Drug Demand Reduction Program. Task orders issued against the IDV by various military medical commands procured immunoassay reagents and kits from Immunalysis Corp. to support substance abuse screening programs. Reagents were acquired for fentanyl, norfentanyl, and differentiating fentanyl from non-fentanyl substances. Delivery...
The Department of the Navy Bureau of Medicine and Surgery awarded Siemens Healthcare Diagnostics Inc. a single award indefinite delivery contract with a potential value of $4,504,500 to provide fentanyl reagent kits. Under this contract vehicle, Siemens Healthcare Diagnostics Division has received four firm fixed price delivery orders totaling $546,000 to supply ARK FENTANYL II products and services in support of the Bureau's medical research and healthcare programs. Performance is to take place...
The U.S. Department of the Navy's Bureau of Medicine and Surgery has awarded a single-award, indefinite delivery contract (IDC) to Microgenics Corporation's Clinical Diagnostics Division for the procurement of MDMA/MDA reagent kits. The $1,154,822.40 contract has a performance period from March 2024 to March 2029. This IDC will provide the Department of Defense Drug Demand Reduction Program with a variety of immunoassay reagent test kits and related laboratory supplies to support substance abuse...
The federal contract IDV was awarded to Alere San Diego, Inc., a division of Abbott Laboratories, to provide immunoassay reagents, test kits, calibrators, controls, and associated equipment maintenance to detect and quantify substances such as fentanyl, norfentanyl, and synthetic cannabinoids. The contract has a $85,923.57 ceiling value and a period of performance through July 2027. Two delivery orders have been issued under this IDV by the Department of Transportation Federal Aviation...
The Defense Logistics Agency Troop Support Medical awarded an indefinite delivery contract to Abbott Rapid DX North America LLC, doing business as Alere, with a potential value of $119.5 million. Alere is a subsidiary of Abbott Laboratories. Under this IDV, eleven firm fixed price delivery orders were issued for a total of approximately $150 million to procure COVID-19 test kits from Alere's Lockhart, Florida facility. Tests supplied include Abbott's BinaxNOW COVID-19 antigen self tests and...
The Department of Defense (DoD) has awarded Microgenics Corporation, a subsidiary of Thermo Electron Corporation, an indefinite delivery contract (IDC) worth up to $5,515,434.90 to provide benzodiazepine immunoassay reagent kits and related laboratory supplies in support of the DoD Drug Demand Reduction Program (DDRP). This single-award IDC has a period of performance through April 30, 2028 and does not utilize any set-aside designations. Under this IDC, Microgenics has received numerous...
  • N0018924DZ013
    Indefinite Delivery Contract
  • 18
    Federal Contract Awards

The Department of the Navy Bureau of Medicine and Surgery has awarded Alere San Diego, Inc. dba Immunalysis Corporation, a subsidiary of Abbott Laboratories Inc., a single-award indefinite delivery contract for the procurement of OXYCODONE & OXYMORPHONE REAGENT KITS. This $907,680.00 contract, awarded on February 15, 2024, supports the acquisition of immunoassay reagents, test kits, calibrators, and controls to detect and quantify substances like fentanyl, norfentanyl, and synthetic cannabinoids. The contract has an ordering period through June 14, 2030 and has been utilized by Navy, Army, and Defense Health Agency facilities to fulfill task orders ranging from approximately $42,000 to over $340,000 for clinical testing and substance abuse screening programs. No set-aside designations were applied to this contract. Alere San Diego has a history of providing similar reagents, test kits, and technical services to federal agencies, including the Departments of Defense, Transportation, Justice, and Veterans Affairs to support their mandatory drug testing initiatives.

Generated 5/16/24, 9:08 AM